NBIS vs LGND vs GPUS vs ANET vs VRT

For growth investors, Nebius Group N.

V. (NBIS) is the stronger pick with 350. 9% revenue growth year-over-year, versus -31. 8% for Hyperscale Data, Inc. (GPUS). Arista Networks, Inc. (ANET) offers the better valuation at 51. 5x trailing P/E (40. 0x forward), making it the more compelling value choice. Analysts rate Nebius Group N. V. (NBIS) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Arista Networks, Inc.

(ANET) is the cheapest at 51. 5x versus Nebius Group N. V. at 1679. 7x. On forward P/E, Ligand Pharmaceuticals Incorporated is actually cheaper at 23. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Vertiv Holdings Co (VRT) delivered a total return of +1380%, compared to -100.

0% for Hyperscale Data, Inc. (GPUS). Over 10 years, the gap is even starker: ANET returned +33. 7% versus GPUS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ligand Pharmaceuticals Incorporated (LGND) is the lower-risk stock at 0.

99β versus Nebius Group N. V. 's 3. 07β — meaning NBIS is approximately 210% more volatile than LGND relative to the S&P 500. On balance sheet safety, Ligand Pharmaceuticals Incorporated (LGND) carries a lower debt/equity ratio of 1% versus 58% for Hyperscale Data, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Nebius Group N.

V. (NBIS) is pulling ahead at 350. 9% versus -31. 8% for Hyperscale Data, Inc. (GPUS). On earnings-per-share growth, the picture is similar: Vertiv Holdings Co grew EPS 166. 4% year-over-year, compared to -107. 5% for Ligand Pharmaceuticals Incorporated. Over a 3-year CAGR, NBIS leads at 239. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Arista Networks, Inc.

(ANET) is the more profitable company, earning 39. 0% net margin versus -52. 7% for Hyperscale Data, Inc. — meaning it keeps 39. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ANET leads at 42. 8% versus -112. 5% for NBIS. At the gross margin level — before operating expenses — LGND leads at 93. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Ligand Pharmaceuticals Incorporated (LGND) trades at 23.

6x forward P/E versus 53. 0x for Vertiv Holdings Co — 29. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ANET: 31. 4% to $186. 25.

In this comparison, GPUS (100.

0% yield) pays a dividend. NBIS, LGND, ANET, VRT do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Ligand Pharmaceuticals Incorporated (LGND) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

99)). Vertiv Holdings Co (VRT) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LGND: +73. 0%, VRT: +33. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (NBIS (Communication Services) and LGND (Healthcare) and GPUS (Industrials) and ANET (Technology) and VRT (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: NBIS is a mid-cap high-growth stock; LGND is a small-cap high-growth stock; GPUS is a small-cap income-oriented stock; ANET is a mid-cap high-growth stock; VRT is a mid-cap high-growth stock. GPUS pays a dividend while NBIS, LGND, ANET, VRT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.